FDA alignment on a single-dose Phase 3 study design and potential single-trial registration pathway further strengthens the ...
An artificial intelligence system that operates like a collaborative team of medical experts could accelerate clinical trial ...
Turn Therapeutics, Inc. (NASDAQ: TTRX), a clinical-stage biotechnology company developing targeted, non-systemic therapies for inflammatory skin diseases, today announced the completion of a ...
A novel intravitreal axitinib hydrogel demonstrated durable disease control in patients with treatment-naive neovascular age-related macular degeneration (AMD), with superior maintenance of visual ...
Detailed price information for Tvardi Therapeutics Inc (TVRD-Q) from The Globe and Mail including charting and trades.
A systematic review and meta-analysis of 8 observational studies found that greater obstructive sleep apnea severity was ...
A new study published in JMIR XR and Spatial Computing demonstrates that the way virtual reality therapeutics (VRx) are ...
Kura Oncology is positioning ziftomenib (KOMZIFTI) as a combination backbone in AML, not just a relapsed/refractory ...
Testing how quickly a biodegradable plastic actually breaks down in the environment can take months, sometimes years, of lab ...
ATAI completes dosing in the phase IIb Elumina study of VLS-01 for treatment-resistant depression, with top-line efficacy and ...
An artificial intelligence system that operates like a collaborative team of medical experts could accelerate clinical trial design, one of the most difficult steps in drug development, according to a ...
Securing central venous access in neonates and infants is one of the most technically demanding tasks in pediatric anesthesia ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results